{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:31:17Z","timestamp":1789543877485,"version":"build-2803163510"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017190","name":"Anti Doping Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Anabolic androgenic steroids (AAS) may exert effects through the insulin-like growth factor (IGF) system. We compared the IGF system in male and female recreational athletes who were current or former AAS users and non-users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The cross-sectional study included 80 active AAS users (19 women), 26 former users (8 women), and 58 age- and sex-matched non-users (16 women). Participants underwent clinical examination, echocardiography, and measurement of circulating IGF-1, IGF-2, IGF bioactivity, IGF-binding proteins (IGFBPs), pregnancy-associated plasma protein-A (PAPP-A) and -A2 (PAPP-A2), and stanniocalcin-1 (STC1) and \u22122 (STC2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In active AAS users, IGF-2 levels were reduced by 36.1% vs. former users and 38.4% vs. non-users (P &amp;lt; .001), and IGFBP-3 levels were 13.6% and 35.8% lower (P &amp;lt; .001). STC2 was increased in AAS-using men only, being 24.5% higher than former users (P = .029) and 45.7% higher than non-users (P &amp;lt; .001). PAPP-A was higher in non-using men than women, whereas levels were similar in active users. Differences remained after adjustment for age, sex, body fat, exercise and strength training, family history of coronary disease, smoking, alcohol, and drug use. No group differences were observed for IGF-1, bioactive IGF, IGFBP-2, or PAPP-A2. Cumulative lifetime AAS exposure was associated with IGF-2, IGFBP-3, and STC2 in multivariable models. Higher IGF-2 and IGFBP-3 associated with lower left ventricular mass, higher left ventricular ejection fraction, and better diastolic function, whereas higher STC2 associated with adverse outcomes (all P &amp;lt; .05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Illicit AAS use is associated with persistent, sex-specific alterations in the IGF\u2013PAPP-A\u2013STC2 axis, potentially contributing to cardiovascular risk in recreational athletes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag037","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:48:03Z","timestamp":1771418883000},"page":"336-346","source":"Crossref","is-referenced-by-count":1,"title":["IGF\u2013PAPP-A\u2013stanniocalcin axis and androgenic anabolic steroid use in men and women"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9182-3393","authenticated-orcid":false,"given":"Laust Frisenberg","family":"Buhl","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]},{"name":"OPEN Patient Data Explorative Network (OPEN), Odense University Hospital, Region of Southern Denmark , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Lehmann","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]},{"name":"OPEN Patient Data Explorative Network (OPEN), Odense University Hospital, Region of Southern Denmark , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2258-3107","authenticated-orcid":false,"given":"Yeliz","family":"Bulut","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Copenhagen University Hospital Rigshospitalet , 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Hasific","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Harders","sequence":"additional","affiliation":[{"name":"Department of Radiology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-8025","authenticated-orcid":false,"given":"Dorte","family":"Glintborg","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne S","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-8854","authenticated-orcid":false,"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[{"name":"Center for Preventive Doping Research, Institute of Biochemistry, German Sport University , 50933 Cologne ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3019-6775","authenticated-orcid":false,"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Copenhagen University Hospital Rigshospitalet , 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Jarl\u00f8v","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Copenhagen University Hospital Rigshospitalet , 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Internal Medicine, Endocrinology Unit, Holb\u00e6k Hospital , 4300 Holb\u00e6k ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes S","family":"Lindholt","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic and Vascular Surgery, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]},{"name":"Department of Cardiology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-0961","authenticated-orcid":false,"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-0889","authenticated-orcid":false,"given":"Rikke","family":"Hjortebjerg","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , 5230 Odense ,","place":["Denmark"]},{"name":"Steno Diabetes Center Odense, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"4","key":"2026033105163291100_lvag037-B1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.pcl.2007.04.003","article-title":"The history of the development of anabolic-androgenic steroids","volume":"54","author":"Dotson","year":"2007","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"2026033105163291100_lvag037-B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/healthcare9010097","article-title":"Adverse effects of anabolic-androgenic steroids: a literature review","volume":"9","author":"Albano","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"2026033105163291100_lvag037-B3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.20882\/adicciones.88","article-title":"Human enhancement drugs and the pursuit of perfection","volume":"24","author":"McVeigh","year":"2012","journal-title":"Adicciones"},{"issue":"4","key":"2026033105163291100_lvag037-B4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"key":"2026033105163291100_lvag037-B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2026033105163291100_lvag037-B6","doi-asserted-by":"publisher","first-page":"R201","DOI":"10.1530\/EJE-19-0071","article-title":"ENDOCRINE HISTORY: the history of discovery, synthesis and development of testosterone for clinical use","volume":"180","author":"Nieschlag","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2026033105163291100_lvag037-B7"},{"issue":"21","key":"2026033105163291100_lvag037-B8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"2026033105163291100_lvag037-B9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/sms.14172","article-title":"Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes","volume":"32","author":"Fyksen","year":"2022","journal-title":"Scand J Med Sci Sports"},{"key":"2026033105163291100_lvag037-B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ahj.2018.06.010","article-title":"Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids","volume":"203","author":"Rasmussen","year":"2018","journal-title":"Am Heart J"},{"issue":"12","key":"2026033105163291100_lvag037-B11","doi-asserted-by":"publisher","first-page":"e2451013","DOI":"10.1001\/jamanetworkopen.2024.51013","article-title":"Coronary microvascular dysfunction years after cessation of anabolic androgenic steroid use","volume":"7","author":"Bulut","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2026033105163291100_lvag037-B12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.124.071117","article-title":"Cardiovascular disease in anabolic androgenic steroid users","volume":"151","author":"Windfeld-Mathiasen","year":"2025","journal-title":"Circulation"},{"issue":"9","key":"2026033105163291100_lvag037-B13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s40279-017-0709-z","article-title":"Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: a systematic review and meta-analysis","volume":"47","author":"Christou","year":"2017","journal-title":"Sports Med"},{"issue":"8","key":"2026033105163291100_lvag037-B14","doi-asserted-by":"publisher","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"issue":"11):","key":"2026033105163291100_lvag037-B15","doi-asserted-by":"publisher","first-page":"e3709","DOI":"10.1210\/clinem\/dgaf157","article-title":"Characterisation of Leydig cell dysfunction in previous illicit androgen users","volume":"110","author":"Bulut","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026033105163291100_lvag037-B16","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1210\/clinem\/dgad551","article-title":"Persistently decreased quality of life and its determinants in previous illicit androgen users","volume":"109","author":"Bulut","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026033105163291100_lvag037-B17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/jama.2024.3180","article-title":"Mortality among users of anabolic steroids","volume":"331","author":"Windfeld-Mathiasen","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"2026033105163291100_lvag037-B18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11154-020-09616-y","article-title":"How the love of muscle can break a heart: impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health","volume":"22","author":"McCullough","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2026033105163291100_lvag037-B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tem.2009.04.002","article-title":"Role of IGF-I in skeletal muscle mass maintenance","volume":"20","author":"Clemmons","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"2026033105163291100_lvag037-B20","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.15252\/emmm.201707950","article-title":"One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology","volume":"9","author":"Argente","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2026033105163291100_lvag037-B21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","article-title":"Sex steroids and the GH axis: implications for the management of hypopituitarism","volume":"31","author":"Birzniece","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"7","key":"2026033105163291100_lvag037-B22","doi-asserted-by":"publisher","first-page":"e2664","DOI":"10.1210\/clinem\/dgab129","article-title":"Serum insulin-like factor 3 levels are reduced in former androgen users, suggesting impaired Leydig cell capacity","volume":"106","author":"Rasmussen","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2026033105163291100_lvag037-B23","doi-asserted-by":"publisher","first-page":"829940","DOI":"10.3389\/fspor.2022.829940","article-title":"Studies of IGF-I and klotho protein in relation to anabolic-androgenic steroid and growth hormone administrations","volume":"4","author":"Lehtihet","year":"2022","journal-title":"Front Sports Act Living"},{"issue":"1","key":"2026033105163291100_lvag037-B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","article-title":"Insulin-like growth factor-1 deficiency and metabolic syndrome","volume":"14","author":"Aguirre","year":"2016","journal-title":"J Transl Med"},{"key":"2026033105163291100_lvag037-B25","doi-asserted-by":"publisher","first-page":"154886","DOI":"10.1016\/j.metabol.2021.154886","article-title":"Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4","volume":"124","author":"Hjortebjerg","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"2026033105163291100_lvag037-B26","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JME-17-0236","article-title":"PAPP-A and cancer","volume":"61","author":"Conover","year":"2018","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"2026033105163291100_lvag037-B27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/ijms25042014","article-title":"The IGF\u2014PAPP-A\u2014stanniocalcin axis in Serum and ascites associates with prognosis in patients with ovarian cancer","volume":"25","author":"Hjortebjerg","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026033105163291100_lvag037-B28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fendo.2020.00614","article-title":"Pregnancy-associated plasma protein-A2 is associated with mortality in patients with lung cancer","volume":"11","author":"Hjortebjerg","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"2026033105163291100_lvag037-B29","doi-asserted-by":"publisher","first-page":"e220451","DOI":"10.1530\/EC-22-0451","article-title":"The STC2-PAPP-A-IGFBP4-IGF1 axis and its associations to mortality and CVD in T2D","volume":"12","author":"Gude","year":"2023","journal-title":"Endocr Connect"},{"issue":"11","key":"2026033105163291100_lvag037-B30","doi-asserted-by":"publisher","first-page":"e4083","DOI":"10.1210\/clinem\/dgaa617","article-title":"Local IGF bioactivity associates with high PAPP-A activity in the pericardial cavity of cardiovascular disease patients","volume":"105","author":"Hjortebjerg","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026033105163291100_lvag037-B31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tem.2013.12.002","article-title":"New insights into IGF-1 signaling in the heart","volume":"25","author":"Troncoso","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2026033105163291100_lvag037-B32","doi-asserted-by":"publisher","first-page":"e078558","DOI":"10.1136\/bmjopen-2023-078558","article-title":"Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the fitness doping in Denmark (FIDO-DK) study","volume":"14","author":"Buhl","year":"2024","journal-title":"BMJ Open"},{"issue":"8","key":"2026033105163291100_lvag037-B33","doi-asserted-by":"publisher","first-page":"e2526636","DOI":"10.1001\/jamanetworkopen.2025.26636","article-title":"Illicit anabolic steroid use and cardiovascular Status in men and women","volume":"8","author":"Buhl","year":"2025","journal-title":"JAMA Netw Open."},{"issue":"5","key":"2026033105163291100_lvag037-B34","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1210\/jc.2013-3060","article-title":"Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays","volume":"99","author":"Friedrich","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026033105163291100_lvag037-B35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026033105163291100_lvag037-B36","doi-asserted-by":"publisher","first-page":"1193742","DOI":"10.3389\/fendo.2023.1193742","article-title":"Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins","volume":"14","author":"Hjortebjerg","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026033105163291100_lvag037-B37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jc.2002-021349","article-title":"Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 Serum levels in patients with active thyroid eye disease","volume":"88","author":"Krassas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026033105163291100_lvag037-B38","doi-asserted-by":"publisher","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol\u2014Endocrinol Metab"},{"issue":"1","key":"2026033105163291100_lvag037-B39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2369-14-80","article-title":"Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study","volume":"14","author":"Reinhard","year":"2013","journal-title":"BMC Nephrol."},{"key":"2026033105163291100_lvag037-B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ghir.2018.05.002","article-title":"IGFBP-4 and PAPP-A in normal physiology and disease","volume":"41","author":"Hjortebjerg","year":"2018","journal-title":"Growth Horm IGF Res"},{"issue":"15","key":"2026033105163291100_lvag037-B41","doi-asserted-by":"publisher","first-page":"e15793","DOI":"10.14814\/phy2.15793","article-title":"Stanniocalcin-2 inhibits skeletal muscle growth and is upregulated in functional overload-induced hypertrophy","volume":"11","author":"Lionikas","year":"2023","journal-title":"Physiol Rep"},{"key":"2026033105163291100_lvag037-B42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2020.00011","article-title":"New insights into physiological and pathophysiological functions of stanniocalcin 2","volume":"11:","author":"Joshi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026033105163291100_lvag037-B43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/(SICI)1520-7560(199909\/10)15:5&lt;314::AID-DMRR56&gt;3.0.CO;2-E","article-title":"Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes","volume":"15","author":"Frystyk","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"2026033105163291100_lvag037-B44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/cen.12446","article-title":"Insulin-like growth factor-II: its role in metabolic and endocrine disease","volume":"80","author":"Livingstone","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026033105163291100_lvag037-B45","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ejendo\/lvaf038","article-title":"The influence of gender-affirming hormone therapy on serum concentrations of hormone-binding proteins","volume":"192","author":"Stangl","year":"2025","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2026033105163291100_lvag037-B46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/edrv.18.6.0321","article-title":"Insulin-like growth factor-binding proteins in Serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"issue":"2-3","key":"2026033105163291100_lvag037-B47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ghir.2014.01.002","article-title":"Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain","volume":"24","author":"Gr\u00f6nbladh","year":"2014","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"2026033105163291100_lvag037-B48","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/jcsm.12472","article-title":"Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men","volume":"10","author":"Gharahdaghi","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2026033105163291100_lvag037-B49","doi-asserted-by":"publisher","first-page":"313605","DOI":"10.1155\/2013\/313605","article-title":"The effect of anabolic steroid administration on passive stretching-induced expression of mechano-growth factor in skeletal muscle","volume":"2013","author":"Ikeda","year":"2013","journal-title":"ScientificWorldJournal."},{"issue":"3","key":"2026033105163291100_lvag037-B50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.70252\/QFNY6413","article-title":"The effects of anabolic-androgenic steroids on gene expression in skeletal muscle: a systematic review","volume":"16","author":"Pelton","year":"2023","journal-title":"Int J Exerc Sci"},{"issue":"3","key":"2026033105163291100_lvag037-B51","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjp.2008.165","article-title":"Pharmacology of anabolic steroids","volume":"154","author":"Kicman","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag037\/67007937\/lvag037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/3\/336\/67007937\/lvag037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/3\/336\/67007937\/lvag037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:16:42Z","timestamp":1774948602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/3\/336\/8492668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag037","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,19]]}}}